Suppr超能文献

促肾上腺皮质激素受体(MC2R)特异性:我们对其潜在分子机制了解多少?

ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

作者信息

Fridmanis Davids, Roga Ance, Klovins Janis

机构信息

Latvian Biomedical Research and Study Centre , Riga , Latvia.

出版信息

Front Endocrinol (Lausanne). 2017 Feb 6;8:13. doi: 10.3389/fendo.2017.00013. eCollection 2017.

Abstract

Coincidentally, the release of this Research Topic in Frontiers in Endocrinology takes place 25 years after the discovery of the adrenocorticotropic hormone receptor (ACTHR) by Mountjoy and colleagues. In subsequent years, following the discovery of other types of mammalian melanocortin receptors (MCRs), ACTHR also became known as melanocortin type 2 receptor (MC2R). At present, five types of MCRs have been reported, all of which share significant sequence similarity at the amino acid level, and all of which specifically bind melanocortins (MCs)-a group of biologically active peptides generated by proteolysis of the proopiomelanocortin precursor. All MCs share an identical -H-F-R-W- pharmacophore sequence. α-Melanocyte-stimulating hormone (α-MSH) and adrenocorticotropic hormone (ACTH) are the most extensively studied MCs and are derived from the same region. Essentially, α-MSH is formed from the first 13 amino acid residues of ACTH. ACTHR is unique among MCRs because it binds one sole ligand-ACTH, which makes it a very attractive research object for molecular pharmacologists. However, much research has failed, and functional studies of this receptor are lagging behind other MCRs. The reason for these difficulties has already been outlined by Mountjoy and colleagues in their publication on ACTHR coding sequence discovery where the Cloudman S91 melanoma cell line was used for receptor expression because it was a "more sensitive assay system." Subsequent work showed that ACTHR could be successfully expressed only in endogenous MCR-expressing cell lines, since in other cell lines it is retained within the endoplasmic reticulum. The resolution of this methodological problem came in 2005 with the discovery of melanocortin receptor accessory protein, which is required for the formation of functionally active ACTHR. The decade that followed this discovery was filled with exciting research that provided insight into the molecular mechanisms underlying the action of ACTHR. The purpose of this review is to summarize the advances in this fascinating research field.

摘要

巧合的是,《内分泌前沿》上这个研究专题的发布,是在芒乔伊及其同事发现促肾上腺皮质激素受体(ACTHR)25年后。在随后的几年里,随着其他类型哺乳动物黑皮质素受体(MCR)的发现,ACTHR也被称为黑皮质素2型受体(MC2R)。目前,已报道了五种类型的MCR,它们在氨基酸水平上都具有显著的序列相似性,并且都特异性结合黑皮质素(MC)——一组由阿片促黑素皮质素原前体蛋白水解产生的生物活性肽。所有的MC都有相同的-H-F-R-W-药效基团序列。α-黑素细胞刺激素(α-MSH)和促肾上腺皮质激素(ACTH)是研究最广泛的MC,且它们来自同一区域。从本质上讲,α-MSH由ACTH的前13个氨基酸残基组成。ACTHR在MCR中是独特的,因为它只结合一种配体——ACTH,这使其成为分子药理学家非常有吸引力的研究对象。然而,许多研究都失败了,对该受体的功能研究也落后于其他MCR。芒乔伊及其同事在关于ACTHR编码序列发现的出版物中已经概述了这些困难的原因,其中使用Cloudman S91黑色素瘤细胞系进行受体表达,因为它是一个“更灵敏的检测系统”。随后的研究表明,ACTHR只有在内源性表达MCR的细胞系中才能成功表达,因为在其他细胞系中它会被滞留在内质网中。2005年随着黑皮质素受体辅助蛋白的发现,这个方法学问题得到了解决,该蛋白是形成功能活性ACTHR所必需的。在这一发现之后的十年里,充满了令人兴奋的研究,这些研究深入了解了ACTHR作用的分子机制。这篇综述的目的是总结这个迷人研究领域的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e73/5292628/5dbf73257509/fendo-08-00013-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验